Psilocybin Therapy

Holly Bennett is the Communications Director at TheraPsil. TheraPsil is a non-profit patient advocacy organization working to legalize psilocybin therapy for Canadians in medical need. Holly has over 8 years of experience in the Canadian cannabis industry including marketing, communications, and patient education, which has prepared her to successfully educate stakeholders about the merits and limitations of psilocybin therapy for therapeutic purposes while advocating for compassionate access. Holly holds a special interest in bioethics and drug policy and is passionate about mental health, harm reduction, and compassionate patient care. In her current role with TheraPsil, she is dedicated to helping change public perception and policy regarding psilocybin-assisted psychotherapy.